MMRi62
MMRi62
Catalog No. M35377
MMRi62 (7-[(2,3-dichlorophenyl)-(pyridin-2-ylamino)methyl]quinolin-8-ol), a ferroptosis inducer targeting MDM2-MDM4 (negative regulators of tumor suppressor p53).
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 67 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 101 | In Stock |
|
| 25MG | 202 | In Stock |
|
| 50MG | 323 | In Stock |
|
| 100MG | 514 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1097 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMMRi62
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Li J, et al. Small-Molecule MMRi62 Induces Ferroptosis and Inhibits Metastasis in Pancreatic Cancer via Degradation of Ferritin Heavy Chain and Mutant p53. Mol Cancer Ther. 2022 Apr 1;21(4):535-545. ?
molnova catalog
related products
-
PRLX-93936 HCL
PRLX-93936 HCL is an analog of erastin and demonstrated synergistic effects against non-small cell lung cancer (NSCLC) cells with cisplatin.
-
FSEN1
FSEN1 is a novel and highly effective non-competitive FSP1 inhibitor with an IC50 value of 313 nM.
-
UAMC-3203
UAMC-3203 is a novel potent, drug-like ferroptosis inhibitor with IC50 of 12 nM.
Cart
sales@molnova.com